Literature DB >> 25512150

A diversity of cancer incidence and mortality in West Asian populations.

Gholamreza Roshandel1, Majid Boreiri2, Alireza Sadjadi3, Reza Malekzadeh2.   

Abstract

BACKGROUND: Western Asia comprises a large proportion of the world population with different ethnicities and religions inhabiting areas of diverse geographic features. The countries of this region have experienced rapid economic growth over the latter half of the 20th century, which continues to this day, resulting in major changes in lifestyle of the population.
OBJECTIVES: The aim of this study was to compare the incidence and mortality of cancer in West Asia using the estimates reported by the International Agency for Research on Cancer (IARC) in Globocan-2012.
METHODS: Countries with high-quality data or national data (based on the definition of the Globocan-2012) were included in the analysis. These included Bahrain, Iran, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, and Turkey. We also found high-quality cancer data from regional cancer registries in 3 Iranian and 3 Turkish provinces. Data on cancer incidence and mortality were collected and described in tables and graphs. Spearman's correlation test was used to assess the correlation between geographic coordinates and the incidence age-standardized rate (ASR; per 100,000 person-years) of cancers.
FINDINGS: Nine countries and 6 regional registries were included. Cancers of the lung (ASR, 33.3), prostate (24.9), bladder (19.1), stomach (16.5), and colorectal (15.9) were the most common malignancies in men. The most common cancers in women were those of the breast (35.4), colorectal (12.1), thyroid (10.3), stomach (9.2), and lung (6.7). The incidence rates of upper gastrointestinal and lung cancers were considerably higher in the northern part of this region, including Turkey and northern Iran compared with southern countries. High incidences of breast, colorectal, prostate, and bladder cancers were found in countries located in the northwest including Jordan, Lebanon, and Turkey.
CONCLUSIONS: The most common cancers differed by country. Consequently, cancer control programs must be tailored to the most common types of cancers in each country. Lack of high-quality data for some West Asian countries was the major limitation of this study. Therefore, as the first step of cancer control programs, it is recommended that well-structured population-based cancer registries be established in all of these countries.
Copyright © 2014 Icahn School of Medicine at Mount Sinai. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  West Asia; cancer; diversity; incidence; mortality

Mesh:

Year:  2014        PMID: 25512150     DOI: 10.1016/j.aogh.2014.09.012

Source DB:  PubMed          Journal:  Ann Glob Health        ISSN: 2214-9996            Impact factor:   2.462


  19 in total

Review 1.  Dealing with the gray zones in the management of gastric cancer: The consensus statement of the İstanbul Group.

Authors:  Erman Aytaç; Fatih Aslan; Bahattin Çicek; Sibel Erdamar; Bengi Gürses; Koray Güven; Okan Falay; Tayfun Karahasanoğlu; Fatih Selçukbiricik; Uğur Selek; Banu Atalar; Emre Balık; Nurdan Tözün; İzzet Rozanes; Ali Arıcan; İsmail Hamzaoğlu; Bilgi Baca; Nil Molinas Mandel; Murat Saruç; Süha Göksel; Gökhan Demir; Fulya Ağaoğlu; Cengiz Yakıcıer; Uğur Özbek; Volkan Özben; Enis Özyar; Ahmet Levent Güner; Özlem Er; Kerim Kaban; Yasemin Bölükbaşı; Dursun Buğra; The İstanbul Group
Journal:  Turk J Gastroenterol       Date:  2019-07       Impact factor: 1.852

2.  Correlation between LSP1 polymorphisms and the susceptibility to breast cancer.

Authors:  Hai Chen; Xiaodong Qi; Ping Qiu; Jiali Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

3.  The Incidence of Hepatocellular Carcinoma in Iran from 1996 to 2016: a Systematic Review and Meta-analysis.

Authors:  Soheil Hassanipour; Majid Mohammadzadeh; Fariborz Mansour-Ghanaei; Mohammad Fathalipour; Farahnaz Joukar; Hamid Salehiniya; Elham Abdzadeh; Ali Akbar Samadani; Hossein-Ali Nikbakht; Morteza Arab-Zozani
Journal:  J Gastrointest Cancer       Date:  2019-06

4.  Incidence of Esophageal Cancer in Iran, a Population-Based Study: 2001-2015.

Authors:  Rahmatollah Moradzadeh; Parvaneh Golmohammadi; Bahman Ghaitasi; Haidar Nadrian; Athareh Najafi
Journal:  J Gastrointest Cancer       Date:  2019-09

5.  Umbelliprenin is Potentially Toxic Against the HT29, CT26, MCF-7, 4T1, A172, and GL26 Cell Lines, Potentially Harmful Against Bone Marrow-Derived Stem Cells, and Non-Toxic Against Peripheral Blood Mononuclear Cells.

Authors:  Mohsen Rashidi; Seyed Ali Ziai; Taraneh Moini Zanjani; Ahad Khalilnezhad; Hamidreza Jamshidi; Davar Amani
Journal:  Iran Red Crescent Med J       Date:  2016-05-14       Impact factor: 0.611

6.  Celastrus orbiculatus extracts induce cell cycle arrest and apoptosis in human esophageal squamous carcinoma ECA-109 cells in vitro via the PI3K/AKT/mTOR signaling pathway.

Authors:  Feng Jin; Guang Zhu; Dan Li; Tengyang Ni; Xiaojun Dai; Haibo Wang; Jun Feng; Yayun Qian; Lin Yang; Shiyu Guo; Tadashi Hisamitsu; Yanqing Liu
Journal:  Oncol Lett       Date:  2017-11-21       Impact factor: 2.967

7.  Combined Genetic Biomarkers Confer Susceptibility to Risk of Urothelial Bladder Carcinoma in a Saudi Population.

Authors:  Nasser Attia Elhawary; Anmar Nassir; Hesham Saada; Anas Dannoun; Omar Qoqandi; Ammar Alsharif; Mohammed Taher Tayeb
Journal:  Dis Markers       Date:  2017-02-27       Impact factor: 3.434

8.  FoxM1 is an independent poor prognostic marker and therapeutic target for advanced Middle Eastern breast cancer.

Authors:  Abdul Khalid Siraj; Poyil Pratheeshkumar; Sandeep Kumar Parvathareddy; Zeeshan Qadri; Saravanan Thangavel; Saeeda Ahmed; Fouad Al-Dayel; Asma Tulbah; Dahish Ajarim; Khawla S Al-Kuraya
Journal:  Oncotarget       Date:  2018-04-03

9.  Mortality Rate and Years of Life Lost Due to Prostate Cancer in Yazd Province, Iran: A 10-year study.

Authors:  Mojtaba Mirzaei; Mahboobehsadat Mirzadeh; Mohsen Mirzaei
Journal:  Sultan Qaboos Univ Med J       Date:  2018-01-10

10.  Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer.

Authors:  Huafeng Pan; Yudi Zhu; Wei Wei; Siliang Shao; Xin Rui
Journal:  World J Surg Oncol       Date:  2018-03-20       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.